NEWS AND MEDIA p53-Therapeutics, Inc. Announces New additions to the Executive Management TeamMay72026Time: 12:00 am - 12:00 amRead MoreBiotech Companies are Coming to Life at Ocean State LabsMar272026Time: 12:00 am - 12:00 amRead MoreRI Life Science Hub invests $4.5M in biotech companies. Where it’s going.Nov252025Time: 12:00 am - 12:00 amRead Morep53-Therapeutics is a founding tenant of Ocean State Labs powered by Portal innovations in Providence, Rhode IslandSep252025Time: 12:00 am - 12:00 amRead MoreR.I.’s first life science incubator to open in early 2026, with five inaugural companiesSep252025Time: 12:00 am - 12:00 amRead MoreIntegrated stress response (ISR) activation and apoptosis through HRI kinase by PG3 and other p53 pathway-restoring cancer therapeuticsSep172024Time: 12:00 am - 12:00 amRead Morep53-Therapeutics SAB press releaseJul262024Time: 12:00 am - 12:00 amRead MoreUpdate from 2024 American Association for Cancer Research Meeting in San DiegoApr102024Time: 12:00 am - 12:00 amRead MoreEl-Deiry Lab presentations on p53 drug development research at 2024 American Association for Cancer Research Meeting in San DiegoApr52024Time: 12:00 am - 12:00 amRead MoreDr. El-Deiry co-chairs Global Cancer Consortium’s International Conference entitled “p53 Therapeutics Mini-Symposium” attended by over 500 leading researchers world-wide.Aug172022Time: 12:00 am - 12:00 amRead MorePIPELINE p53-Therapeutics, Inc. CLICK HERE FOR NEWS ARCHIVE
